SMTL ID : 8ous.1

CRYSTAL STRUCTURE OF DLK IN COMPLEX WITH COMPOUND 19

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x W3I: (1S)-1-[4-[6-azanyl-5-(trifluoromethyloxy)pyridin-3-yl]-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]-2-methyl-propan-1-ol(Non-covalent)

W3I.1: 17 residues within 4Å: Chain A: V.20, G.21, G.23, Q.25, V.28, A.39, K.41, I.63, M.79, E.80, F.81, C.82, A.83, Q.84, G.85, Q.86, L.132 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:Q.86, A:L.132 Hydrogen bonds: A:E.80, A:C.82, A:Q.86 Water bridges: A:Q.84, A:Q.86

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Le, K. et al., Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy. J.Med.Chem. (2023)

Release Date

2023-07-26

Peptides

Mitogen-activated protein kinase kinase kinase 12: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase kinase kinase 12

Related Entries With Identical Sequence